Patron Exim Fund Raise of ₹16.68 Cr

Patron Exim Board Meeting Date

Patron Exim intimated BSE of a board meeting on November 2, 2026 to consider unaudited standalone results for the half year ended September 30, 2026. The results are not yet approved.

Patron Exim Annual General Meeting

Patron Exim Ltd held its 4th Annual General Meeting on September 30, 2026. Shareholders approved financial statements, the Managing Director's reappointment, and the secretarial auditor's appointment.

Patron Exim Annual General Meeting

Patron Exim Limited has issued a notice for its AGM scheduled on 30 September 2026. The agenda includes adoption of financials and MD re-appointment.

Patron Exim Other Announcement

Patron Exim appointed A. Shubhangi & Associates as Statutory Auditor for a 60-month term. The appointment was approved by the Board on 08 September 2026.

Patron Exim Annual Report

Patron Exim Limited filed its Annual Report for FY 2025-26, which includes the notice for the upcoming Annual General Meeting scheduled on September 30, 2026.

Patron Exim Board Meeting Outcome

Patron Exim Ltd approved its Directors' Report and appointed a secretarial auditor. It also announced the upcoming 4th Annual General Meeting scheduled for September 30, 2026.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.